Nieuwsfeed
- FluMist Quadrivalent
- Flu Vaccines
- Vaccines
- Transfusion/Donation Fatalities
- FY 2018 Report from the Director
- Blood Safety & Availability
- HIV Home Test Kits
- Exclusive: Verily welcomes Atara Biotherapeutics veteran as new CFO
- 2009 H1N1 (Swine) Flu Virus (Biologics)
- Questions about Vaccines
- Dexcom's spokescelebrity Nick Jonas returns to Super Bowl in new glucose monitor commercial
- Tips for Selecting Digital Health Technology Suppliers
- New Teva CEO Richard Francis reprioritizes to 'get back to growth'
- DC court overrules PhRMA's bid to shut down drug imports from Canada
- FDA commissioner floats ideas on how to better handle the pandemic
- Sanofi renews social campaign to remind that vaccines let people ‘Dream Big’
- Daiichi Sankyo to build Japan's first mRNA vaccine manufacturing facility — report
- Bayer taps Roche's Bill Anderson to lead pharma giant as CEO
- AstraZeneca moves forward with a $360M API plant in Ireland
- Ovid brings two Big Pharma vets on board as new CMO, head of epilepsy research
- Consumer Updates
- New option for HR+/HER2- treatment-resistant breast cancer patients
- Biotech receives award from DOD; Regulators accept Appili Therapeutics' NDA
- GSK signs deal for Cytel’s Solara clinical trial strategy platform
- M&B Sciences unveils NeighborhoodTrials mobile app for patients
- Olezarsen FDA approval improves outlook for Ionis Pharmaceuticals, says GlobalData
- Merck-Novartis revolving door spins again as AI leader Iya Khalil switches pharmas
- After a bad quarter, Illumina focuses on new DNA sequencing platform
- How Purdue's $272M addiction payout funded a new home for its discarded non-opioid research
- Navigating Research Can Be Tricky in Financially Unstable Times
- The drug pricing president: Biden warns of veto for any IRA repeal attempts
- Roche reports positive data from Phase III trial of PNH therapy
- Swiss rare disease biotech withdraws IPO to update its Nasdaq plans
- As clinical trials get more complex, software startup Faro bags $20M to help visualize them
- A small change in your inbox each morning
- Guest Post — Introducing Two New Toolkits to Advance Inclusion in Scholarly Communication: Part 1
- We zoeken een bestuurslid HR
- USP is Announcing a Proposal to Modify the Glass General Chapter
- Syneos and Haystack announce partnership to improve patient enrolment
- Last chance to share your views on the Health Policy Platform, the Live webinars and the EU Health Award!
- DCRF nieuwsbrief: Startsein Europese benchmark klinische studies, CTR; hulpmiddelen, fabels en quick guide, en Patiëntenparticipatie
- CDER Scientific Review Documents Supporting Emergency Use Authorizations for Drug and Biological Therapeutic Products | COVID-19
- FDA assembles adcomm to review GSK's Jemperli trial plans in rectal cancer
- AI Company Narrativa Teams Up with the Leukemia and Lymphoma Society to Improve Regulatory Documentation Process
- Researchers pan pharma DTC advertising for high spending on low-value drugs — JAMA report
- FDA Roundup: February 7, 2023
- Global Health Crisis Provides Learning Opportunities Moving Forward
- Gardasil
- Drugs@FDA Data Files
- How early planning leads to successful market access and drug launch in Europe
Op de hoogte blijven van actueel nieuws, bijeenkomsten en publieke consultaties